Feedback / Questions
ubidecarenone IV (BPM 31510 IV) - BPGbio
https://www.businesswire.com/news/home/20240912311165/en/BPGbio-Presents-Phase-2b-BPM31510-Glioblastoma-Trial-in-Progress-Update-and-Pioneering-Comprehensive-Quinomics-Assessment-at-the-ESMO-Congress-2024
Sep 12, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next